These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11859114)

  • 1. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties.
    Masli S; Turpie B; Hecker KH; Streilein JW
    J Immunol; 2002 Mar; 168(5):2264-73. PubMed ID: 11859114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells.
    Masli S; Turpie B; Streilein JW
    Int Immunol; 2006 May; 18(5):689-99. PubMed ID: 16569680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
    Takeuchi M; Alard P; Streilein JW
    J Immunol; 1998 Feb; 160(4):1589-97. PubMed ID: 9469414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
    Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
    J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.
    Takeuchi M; Alard P; Verbik D; Ksander B; Streilein JW
    Immunology; 1999 Dec; 98(4):576-83. PubMed ID: 10594691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells.
    Mir FA; Contreras-Ruiz L; Masli S
    Immunology; 2015 Dec; 146(4):547-56. PubMed ID: 26458493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation.
    Takaki H; Minoda Y; Koga K; Takaesu G; Yoshimura A; Kobayashi T
    Genes Cells; 2006 Aug; 11(8):871-82. PubMed ID: 16866871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eye's view of antigen presentation.
    Streilein JW; Masli S; Takeuchi M; Kezuka T
    Hum Immunol; 2002 Jun; 63(6):435-43. PubMed ID: 12039518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
    Wilbanks GA; Streilein JW
    Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells.
    Yoshida M; Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transforming growth factor-beta on bone marrow macrophage Ia expression induced by cytokines.
    Gollnick SO; Cheng HL; Grande CC; Thompson D; Tomasi TB
    J Interferon Cytokine Res; 1995 May; 15(5):485-91. PubMed ID: 7648451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta up-regulates CD40-engaged IL-12 production of mouse Langerhans cells.
    Tada Y; Asahina A; Nakamura K; Miyazono K; Tomura M; Fujiwara H; Tamaki K
    Eur J Immunol; 2001 Jan; 31(1):294-300. PubMed ID: 11265646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.